Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.61 |
| ▸ | NPY1R | P25929 | 8/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.61 |
| ▸ | NPY2R | P49146 | 4/20 | 0.61 |
| ▸ | TFPI | P10646 | 1/20 | 0.57 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30924757 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL29835305 | 0.96 | TFPI (0.61) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30612278 | 0.94 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL30924753 | 0.93 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30924746 | 0.92 | TFPI (0.59) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30924750 | 0.91 | TFPI (0.60) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL30924735 | 0.90 | TFPI (0.59) | NPY4RNPY1RNPY5RNPY2RTFPI | |
| SCHEMBL29434670 | 0.89 | NPY4R (0.65) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31264972 | 0.89 | BACE1 (0.54) | TFPIKISS1R | |
| SCHEMBL30257868 | 0.89 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4313100-A2 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO Pharma, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2022204305-A2 | PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION | GLO PHARMA, INC. (US) | 2022-09-29 | — | — | WO | disclosed |